Search for: "JANSSEN PHARMA V TEVA PHARMA" Results 1 - 20 of 40
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2021, 1:31 am by Rose Hughes
 One option is to file as soon as the clinical trial gets under way, to avoid the very fact of the clinical trail itself becoming prior art (see IPKat: Untested hypothesis in a clinical trial protocol destroys novelty of a method of treatment claim in Australia (Mylan v Sun Pharma). [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets:  Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and… [read post]
5 Mar 2014, 2:46 pm
Janssen Pharmaceuticals, Arkansas Supreme Court – gigantic ($billion+) state AG action verdict on novel theory in statutory quasi-class action·                     Garrett v. [read post]
2 Nov 2011, 2:00 am by Marie Louise
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
25 Jan 2011, 10:58 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Dec 2010, 2:17 am by Kelly
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
30 Dec 2009, 2:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
29 Sep 2009, 11:38 am
  In Re ‘318 Patent Infringement Litigation (a/k/a Janssen Pharma and Synaptech v. [read post]